Trading Day Review: Travere Therapeutics Inc (TVTX) Loses Momentum, Closing at 15.21

Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of Travere Therapeutics Inc (NASDAQ: TVTX) closed at $15.21 in the last session, down -0.33% from day before closing price of $15.26. In other words, the price has decreased by -$0.33 from its previous closing price. On the day, 3.59 million shares were traded. TVTX stock price reached its highest trading level at $15.61 during the session, while it also had its lowest trading level at $13.9.

Ratios:

We take a closer look at TVTX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 2.99 and its Current Ratio is at 3.04. In the meantime, Its Debt-to-Equity ratio is 26.62 whereas as Long-Term Debt/Eq ratio is at 26.27.

Citigroup Upgraded its Neutral to Buy on December 05, 2023, whereas the target price for the stock was revised from $7 to $10.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Oct 04 ’24 when LYONS GARY A sold 40,000 shares for $14.73 per share. The transaction valued at 589,101 led to the insider holds 51,000 shares of the business.

GARY A LYONS bought 40,000 shares of TVTX for $546,000 on Oct 04 ’24. On Sep 30 ’24, another insider, Meckler Jeffrey A, who serves as the Director of the company, sold 40,000 shares for $14.06 each. As a result, the insider received 562,324 and left with 81,000 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TVTX now has a Market Capitalization of 1163435776 and an Enterprise Value of 1241265536. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.55 while its Price-to-Book (P/B) ratio in mrq is 76.78. Its current Enterprise Value per Revenue stands at 6.987 whereas that against EBITDA is -4.513.

Stock Price History:

Over the past 52 weeks, TVTX has reached a high of $15.58, while it has fallen to a 52-week low of $5.12. The 50-Day Moving Average of the stock is 34.46%, while the 200-Day Moving Average is calculated to be 74.03%.

Shares Statistics:

According to the various share statistics, TVTX traded on average about 1.58M shares per day over the past 3-months and 2465290 shares per day over the past 10 days. A total of 75.37M shares are outstanding, with a floating share count of 75.34M. Insiders hold about 1.51% of the company’s shares, while institutions hold 117.58% stake in the company. Shares short for TVTX as of 1726185600 were 8657111 with a Short Ratio of 5.47, compared to 1723680000 on 9295562. Therefore, it implies a Short% of Shares Outstanding of 8657111 and a Short% of Float of 12.73.

Most Popular